Ahmed Idbaih Selected Research

Ahmed Idbaih Research Topics

Disease

94	Neoplasms (Cancer) 03/2024 - 09/2006
62	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 11/2007
52	Glioma (Gliomas) 01/2023 - 09/2006
10	Oligodendroglioma 12/2019 - 08/2008
7	Astrocytoma (Pilocytic Astrocytoma) 12/2022 - 11/2009
5	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2013
4	Histiocytosis 10/2023 - 01/2017
4	Necrosis 01/2023 - 01/2018
4	Erdheim-Chester Disease 01/2022 - 09/2014
4	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 11/2019 - 07/2004
3	Carcinogenesis 12/2018 - 09/2008
2	Ganglioglioma 12/2022 - 11/2018
2	Pinealoma (Pineoblastoma) 07/2022 - 11/2009
2	Lymphoma (Lymphomas) 03/2022 - 01/2012
2	COVID-19 09/2021 - 12/2020
2	Progressive Multifocal Leukoencephalopathy 07/2021 - 06/2021
2	Diabetes Insipidus 09/2019 - 07/2007
2	Circulating Neoplastic Cells 01/2018 - 01/2015
2	Hyperthermia 10/2017 - 01/2017
1	Plexiform Neurofibroma 03/2023
1	Neurofibroma 03/2023
1	Neurilemmoma (Schwannoma) 03/2023
1	Neurofibrosarcoma (MPNST) 03/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Residual Neoplasm 01/2023
1	Hydrocephalus (Hydrocephaly) 07/2022
1	Germinoma 07/2022

Drug/Important Bio-Agent (IBA)

26	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 09/2006
20	Biomarkers (Surrogate Marker)IBA 10/2023 - 09/2007
12	Lomustine (CCNU)FDA Link 10/2023 - 07/2011
11	Bevacizumab (Avastin)FDA Link 10/2023 - 09/2008
9	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023 - 09/2009
9	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 05/2010
9	Procarbazine (Matulane)FDA Link 06/2017 - 03/2010
8	Vincristine (Oncovin)FDA LinkGeneric 06/2017 - 03/2010
7	VemurafenibIBA 01/2022 - 09/2014
6	Codon (Codons)IBA 01/2017 - 07/2007
6	MethyltransferasesIBA 09/2014 - 09/2006
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2007
4	Carboplatin (JM8)FDA LinkGeneric 02/2024 - 01/2016
4	RNA (Ribonucleic Acid)IBA 10/2023 - 11/2009
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2023 - 01/2021
4	AntibodiesIBA 01/2023 - 10/2015
4	NivolumabIBA 01/2023 - 01/2019
4	5- (2'- naphthyl)- 7- 4- chlorophenyl- (2,3,6,8- tetrahydro)pyrrolo- (3,4- e)(1,4)- diazepine- 6- thioxo- 8- (1H,7H)oneIBA 12/2021 - 03/2016
4	alpha-internexinIBA 11/2011 - 05/2008
3	Immune Checkpoint InhibitorsIBA 12/2022 - 07/2021
3	Everolimus FDA Link 12/2022 - 01/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2022 - 12/2020
3	IronIBA 09/2021 - 01/2017
3	Antimitotic AgentsIBA 01/2021 - 12/2015
3	ErbB Receptors (EGF Receptor)IBA 02/2020 - 08/2008
3	Mitogen-Activated Protein KinasesIBA 12/2019 - 11/2009
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 03/2008
3	Histones (Histone)IBA 10/2016 - 01/2014
3	Irinotecan (Camptosar)FDA LinkGeneric 04/2015 - 09/2008
2	marizomibIBA 03/2024 - 01/2021
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2023 - 05/2013
2	Phosphotransferases (Kinase)IBA 09/2023 - 07/2015
2	GadoliniumIBA 03/2022 - 12/2021
2	Tyrosine Kinase InhibitorsIBA 02/2022 - 09/2008
2	Angiogenesis InhibitorsIBA 01/2022 - 09/2008
2	somatostatin receptor 2IBA 01/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 12/2018 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 07/2018 - 07/2018
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2018 - 07/2018
2	Messenger RNA (mRNA)IBA 01/2018 - 11/2010
2	ParaffinIBA 09/2014 - 04/2008
2	Complement System Proteins (Complement)IBA 09/2014 - 05/2011
2	O-(6)-methylguanineIBA 09/2014 - 05/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014 - 09/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013 - 09/2008
2	Alkylating AgentsIBA 11/2007 - 09/2006
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2024
1	NeopterinIBA 10/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2023
1	MTOR InhibitorsIBA 03/2023
1	Hematoxylin (Haematoxylon)IBA 03/2023
1	AZD 6244IBA 03/2023
1	AnthracyclinesIBA 03/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	SulfurtransferasesIBA 10/2022
1	PolyethyleneimineIBA 10/2022
1	Drug CarriersIBA 10/2022
1	carbeneIBA 10/2022
1	PlatinumIBA 10/2022
1	Dihydroxyphenylalanine (Dopa)IBA 09/2022

Therapy/Procedure

42	Drug Therapy (Chemotherapy) 03/2024 - 11/2007
33	Therapeutics 03/2024 - 07/2004
22	Radiotherapy 03/2024 - 09/2010
7	Chemoradiotherapy 03/2024 - 05/2011
7	Precision Medicine 10/2023 - 11/2015
3	Artificial Respiration (Mechanical Ventilation) 09/2021 - 11/2017
2	Immunotherapy 12/2023 - 01/2021
2	Aftercare (After-Treatment) 01/2020 - 01/2020
2	Molecular Targeted Therapy 11/2015 - 09/2008
1	Time-to-Treatment 01/2023
1	Drug Tapering 01/2023
1	Conformal Radiotherapy 12/2022
1	Ventriculostomy 07/2022